ComplianceOnline

Post-Market Clinical Follow-Up Studies - GHTF guidance

  • Date: May 03, 2009
  • Source: www.ghtf.org
Webinar All Access Pass Subscription Abstract:

This document provides guidance in relation to:

  1. the circumstances where a post-market clinical follow-up study is indicated;
  2. the general principles of post-market clinical follow-up studies involving medical devices; and
  3. the use of study information, including, for example, to provide information to update labelling.

This document does not apply to in vitro diagnostic devices.

It explains -

  • The Circumstances Where A Post-Market Clinical Follow-Up Study Is Indicated
  • The Elements Of A Post-Market Clinical Follow-Up Study
  • The Use Of Study Information

Bookmark and Share

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
On Demand Access Anytime
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading